Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
| Actual shortage: | 250 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2422 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
25 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-BUDESONIDE | 0.5MG | SUSPENSION | Resolved | 2022-05-19 | 2022-06-09 | 160994 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Resolved | 2022-01-20 | 2022-06-16 | 153189 |
| ACT ESCITALOPRAM ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-03-31 | 2022-06-17 | 157637 |
| TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2022-03-31 | 2022-06-17 | 157647 |
| TEVA-PROPRANOLOL | 80MG | TABLET | Resolved | 2022-03-31 | 2022-06-17 | 157663 |
| TEVA-NARATRIPTAN | 2.5MG | TABLET | Resolved | 2022-04-08 | 2022-06-17 | 158428 |
| TEVA-TOPISONE | 0.05% | OINTMENT | Resolved | 2022-04-21 | 2022-06-17 | 159192 |
| TEVA-CLOPIDOGREL | 300MG | TABLET | Resolved | 2022-04-28 | 2022-06-17 | 159587 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2022-06-09 | 2022-06-17 | 162283 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Resolved | 2022-06-03 | 2022-07-01 | 161934 |
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Resolved | 2022-02-10 | 2022-07-01 | 154720 |
| TEVA-AMPHETAMINE XR | 5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-05-12 | 2022-07-01 | 160420 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2022-05-19 | 2022-07-01 | 160983 |
| TEVA-CINACALCET | 90MG | TABLET | Resolved | 2022-06-03 | 2022-07-01 | 161937 |
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Resolved | 2022-04-28 | 2022-07-01 | 159590 |
| TEVA-TECNAL | 330MG 40MG 50MG | CAPSULE | Resolved | 2022-02-10 | 2022-07-01 | 154714 |
| TEVA-PREGABALIN | 50MG | CAPSULE | Resolved | 2022-06-03 | 2022-07-01 | 161967 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2022-04-28 | 2022-07-20 | 159578 |
| TEVA-LENOLTEC NO. 1 | 8MG 15MG 300MG | TABLET | Resolved | 2022-06-03 | 2022-07-20 | 161931 |
| TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2022-06-09 | 2022-07-26 | 162291 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64601 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64606 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64609 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64612 |
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
| TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64846 |
| TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64849 |
| RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
| TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64855 |
| TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64858 |